Glycol Chitosan Engineered Autoregenerative Antioxidant Significantly Attenuates Pathological Damages in Models of Age-Related Macular Degeneration

Keyphrases

• Antioxidant 100%
• Oxidative Stress 100%
• Age-related Macular Degeneration 100%
• Pathological Damage 100%
• Glycol chitosan 100%
• Biocompatibility 50%
• Nanoceria 50%
• Therapeutic Strategies 25%
• Therapeutic Intervention 25%
• Reactive Oxygen Species 25%
• Developing Countries 25%
• Irreversible Blindness 25%
• In Vivo Model 25%
• Angiogenic 25%
• Laser-induced Choroidal Neovascularization 25%
• Therapeutic Effect 25%
• Oxidative Damage 25%
• Stress-induced 25%
• Targeted Delivery 25%
• Low Absorption 25%
• Precision Medicine 25%
• Low Water Solubility 25%
• Antioxidant Activity 25%
• Vascular Endothelial Growth Factor Expression 25%
• Unmet Medical Need 25%
• Intracellular Reactive Oxygen Species 25%
• Endothelial Progenitor Cells 25%
• Stress Disorders 25%
• Surface Engineering 25%
• Water-soluble 25%
• Pharmaceutical Products 25%
• Clinical Implementation 25%
• Absorption Distribution 25%
• Advanced Formulations 25%
• Non-enzymatic Antioxidants 25%
• Engineered Water Systems 25%
• Water Surface 25%
• Water Solubility 25%
• Alternative Therapeutics 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoceria 50%